Every person responds differently
Zepbound and Mounjaro are dual agonists, meaning they activate both GLP-1 receptors and gastric inhibitory polypeptide receptors (GIPs), which may offer added benefits for some people
For many patients, paying $349 monthly is simpler and faster than navigating assistance applications, even if they might qualify for free medication
The STEP (Semaglutide Treatment Effect in People with obesity) trial program showed average weight reductions of approximately 15% of initial body weight over 68 weeks in individuals without diabetes, with somewhat lower reductions (about 9-10%) in those with type 2 diabetes
Melissa-Rosina Pasqua, the studys first author, endocrinologist at the MUHC and doctoral student at The Institute, who coordinated the study
The biological effect is thus decoupled from the plasma half-life and the magnitude of the dose, provided the minimal signaling threshold is met [4, 5]